Back
Open Access

Real-world effectiveness of MAVacamtEN in Canada: insights from the MAVEN study

Session: Effects in hypertrophic cardiomyopathy
Topic: Hypertrophic Cardiomyopathy
Speaker: Doctor A. Crean (Manchester, GB)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Andrew Crean

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)
0 follower

5 more presentations in this session

Impact of novel maximal wall thickness adjustments on arrhythmic event prediction in hypertrophic cardiomyopathy

Speaker: Doctor R. Amador (Lisbon, PT)

Access
Abstract
Like
Thumbnail

Hypertrophic cardiomyopathy with the three Dutch founder variants in MYBPC3: a natural history and comparison

Speaker: Doctor S. Schoonvelde (Rotterdam, NL)

Access
Abstract
Like
Thumbnail

The adding value of non-invasive assessment of stroke volume during cardiopulmonary exercise testing in hypertrophic cardiomyopathy: beyond O2-pulse

Speaker: Doctor M. Mapelli (Milan, IT)

Access
Abstract
Like
Thumbnail

Unveiling functional impairment in fabry disease: the predominance of peripheral over cardiac factors

Speaker: Doctor F. Re (Roma, IT)

Access
Abstract
Like
Thumbnail

Changes in CMR-derived global longitudinal strain, progression of fibrosis and outcome in hypertrophic cardiomyopathy

Speaker: Doctor A. Aimo (Pisa, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Effects in hypertrophic cardiomyopathy

Speakers: Doctor A. Crean, Doctor R. Amador, Doctor S. Schoonvelde, Doctor M. Mapelli, Doctor F. Re...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources